Gadolite oral suspension of a synthetic crystalline lattice of the lanthanide metal gadolinium and water data

The privately held Sunnyvale, Calif., company said that a Phase III trial has confirmed the tolerability of the MRI contrast agent, and lack of its absorption into the body.

In 250 patients with known or suspected disease in the abdomen or pelvis, Gadolite improved interpretation of scans, which were presented to the analyzing radiologists in the actual digital form, rather than as films. ...